CN106307543A - Nano-liposome with thymol and method for preparing nano-liposome - Google Patents
Nano-liposome with thymol and method for preparing nano-liposome Download PDFInfo
- Publication number
- CN106307543A CN106307543A CN201610697219.0A CN201610697219A CN106307543A CN 106307543 A CN106307543 A CN 106307543A CN 201610697219 A CN201610697219 A CN 201610697219A CN 106307543 A CN106307543 A CN 106307543A
- Authority
- CN
- China
- Prior art keywords
- thymol
- liposome
- nano
- soybean lecithin
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 title claims abstract description 149
- 239000005844 Thymol Substances 0.000 title claims abstract description 74
- 229960000790 thymol Drugs 0.000 title claims abstract description 74
- 239000002502 liposome Substances 0.000 title claims abstract description 26
- 238000000034 method Methods 0.000 title abstract description 7
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims abstract description 20
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims abstract description 19
- 229940083466 soybean lecithin Drugs 0.000 claims abstract description 19
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims abstract description 13
- 229920000053 polysorbate 80 Polymers 0.000 claims abstract description 13
- 238000002360 preparation method Methods 0.000 claims abstract description 12
- 235000012000 cholesterol Nutrition 0.000 claims abstract description 10
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 8
- 238000003760 magnetic stirring Methods 0.000 claims abstract description 8
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 7
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 7
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 6
- 235000006708 antioxidants Nutrition 0.000 claims abstract description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 26
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 claims description 13
- 229930003427 Vitamin E Natural products 0.000 claims description 13
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 13
- 235000019165 vitamin E Nutrition 0.000 claims description 13
- 229940046009 vitamin E Drugs 0.000 claims description 13
- 239000011709 vitamin E Substances 0.000 claims description 13
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 claims description 12
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 12
- 229940030275 epigallocatechin gallate Drugs 0.000 claims description 12
- 239000000243 solution Substances 0.000 claims description 9
- 239000000872 buffer Substances 0.000 claims description 6
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 6
- 239000008055 phosphate buffer solution Substances 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 4
- 239000010661 oregano oil Substances 0.000 claims description 3
- 229940111617 oregano oil Drugs 0.000 claims description 3
- 239000008363 phosphate buffer Substances 0.000 claims description 3
- 239000010678 thyme oil Substances 0.000 claims description 3
- 102000002322 Egg Proteins Human genes 0.000 claims description 2
- 108010000912 Egg Proteins Proteins 0.000 claims description 2
- 230000006837 decompression Effects 0.000 claims description 2
- 235000013345 egg yolk Nutrition 0.000 claims description 2
- 210000002969 egg yolk Anatomy 0.000 claims description 2
- 238000001704 evaporation Methods 0.000 claims description 2
- 230000008020 evaporation Effects 0.000 claims description 2
- 229930014626 natural product Natural products 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- 239000000284 extract Substances 0.000 claims 1
- 238000002604 ultrasonography Methods 0.000 claims 1
- 239000002245 particle Substances 0.000 abstract description 11
- 238000005538 encapsulation Methods 0.000 abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 2
- 230000008569 process Effects 0.000 abstract description 2
- 238000002390 rotary evaporation Methods 0.000 abstract description 2
- 238000013268 sustained release Methods 0.000 abstract description 2
- 239000012730 sustained-release form Substances 0.000 abstract description 2
- 238000009210 therapy by ultrasound Methods 0.000 abstract 1
- 125000003639 thymyl group Chemical group C1(=CC(C)=CC=C1C(C)C)* 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 239000010408 film Substances 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 150000003904 phospholipids Chemical class 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 235000013373 food additive Nutrition 0.000 description 3
- 239000002778 food additive Substances 0.000 description 3
- 230000004224 protection Effects 0.000 description 3
- 238000002525 ultrasonication Methods 0.000 description 3
- 239000000232 Lipid Bilayer Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- WMBWREPUVVBILR-GHTZIAJQSA-N (+)-gallocatechin gallate Chemical compound O([C@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-GHTZIAJQSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 240000007926 Ocimum gratissimum Species 0.000 description 1
- 235000004066 Ocimum gratissimum Nutrition 0.000 description 1
- 238000003917 TEM image Methods 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000010619 basil oil Substances 0.000 description 1
- 229940018006 basil oil Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000000490 cosmetic additive Substances 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- LVJJFMLUMNSUFN-UHFFFAOYSA-N gallocatechin gallate Natural products C1=C(O)C=C2OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C1OC(=O)C1=CC(O)=C(O)C(O)=C1 LVJJFMLUMNSUFN-UHFFFAOYSA-N 0.000 description 1
- 235000021474 generally recognized As safe (food) Nutrition 0.000 description 1
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 229910001410 inorganic ion Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- IYDGMDWEHDFVQI-UHFFFAOYSA-N phosphoric acid;trioxotungsten Chemical compound O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.O=[W](=O)=O.OP(O)(O)=O IYDGMDWEHDFVQI-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23B—PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23B2/00—Preservation of foods or foodstuffs, in general
- A23B2/70—Preservation of foods or foodstuffs, in general by treatment with chemicals
- A23B2/725—Preservation of foods or foodstuffs, in general by treatment with chemicals in the form of liquids or solids
- A23B2/729—Organic compounds; Microorganisms; Enzymes
- A23B2/733—Compounds of undetermined constitution obtained from animals or plants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明公开了一种麝香草酚纳米脂质体及其制备方法,所述麝香草酚纳米脂质体的配方为麝香草酚、大豆卵磷脂、二硬脂酰磷脂酰乙酰胺‑甲氧基聚乙二醇5000、胆固醇、抗氧化剂和吐温80;同时,本发明通过磁力搅拌、旋转蒸发和超声处理工艺,制备出麝香草酚纳米脂质体,所制得的脂质体的平均粒径为96‑105nm,多分散指数为0.196‑0.201,包封率为86.1‑89.3%,该脂质体为近球形结构,常温下贮藏12d仍能保持较好的稳定性。本发明可提高麝香草酚的水分散性、稳定性和生物利用率,且具有持续释放作用。The invention discloses a thymol nano-liposome and a preparation method thereof. The formula of the thymol nano-liposome is thymol, soybean lecithin, distearoylphosphatidylacetamide-methoxy Polyethylene glycol 5000, cholesterol, antioxidant and Tween 80; Simultaneously, the present invention prepares thymol nano-liposomes through magnetic stirring, rotary evaporation and ultrasonic treatment process, and the average particle size of the prepared liposomes is The liposome has a diameter of 96-105nm, a polydispersity index of 0.196-0.201, and an encapsulation efficiency of 86.1-89.3%. The liposome has a nearly spherical structure and can still maintain good stability after being stored at room temperature for 12 days. The invention can improve the water dispersibility, stability and bioavailability of thymol, and has sustained release effect.
Description
技术领域technical field
本发明属于微胶囊包埋技术领域,更具体地说,尤其涉及一种麝香草酚纳米脂质体。同时,本发明还涉及一种麝香草酚纳米脂质体的制备方法。The invention belongs to the technical field of microcapsule embedding, and more specifically relates to a thymol nanoliposome. Simultaneously, the present invention also relates to a preparation method of thymol nano liposome.
背景技术Background technique
麝香草酚又称百里香酚,化学名称为5-甲基-2-异丙基苯酚,存在于百里香油、牛至油、丁香罗勒油等植物精油中,具有特殊香气和较强的防腐杀菌及抗氧化性能,常用于配制胶姆糖、蘑菇香和柑桔等香型香精。麝香草酚通过破坏细胞膜完整性、影响无机离子平衡和pH稳定性而发挥其抑菌性能。麝香草酚苯环上的羟基能够提供H+给自由基,从而延缓氧化过程。此外,麝香草酚还具有潜在的护肝、抗癌和抗肿瘤作用。尽管麝香草酚被FDA认证为GRAS的食品添加剂,但其较差的水分散性和稳定性,限制了其在工业中的应用。通过构建合适的载体,可提高其水溶性,扩大反应界面,并进一步提高其抑菌和抗氧化活性。Thymol, also known as thymol, has a chemical name of 5-methyl-2-isopropylphenol, which exists in plant essential oils such as thyme oil, oregano oil, and clove basil oil. Antioxidant properties, often used in the preparation of flavors such as gummies, mushrooms and citrus. Thymol exerts its antibacterial properties by destroying the integrity of cell membranes, affecting the balance of inorganic ions and pH stability. The hydroxyl group on the benzene ring of thymol can provide H + to free radicals, thereby delaying the oxidation process. In addition, thymol also has potential liver protection, anticancer and antitumor effects. Although thymol is certified as a GRAS food additive by the FDA, its poor water dispersibility and stability limit its application in industry. By constructing a suitable carrier, its water solubility can be improved, the reaction interface can be expanded, and its antibacterial and antioxidant activities can be further improved.
脂质体(liposome)是由磷脂或其类似物分散于水相中形成的具有双分子层结构的封闭囊泡。目前,认同较广的脂质体形成机制是磷脂和水分子之间相互作用,磷脂极性头部位于脂双层内外表面,疏水性尾部位于脂双层中间,自发形成了双分子层囊泡结构。这种结构特性使得脂质体可以同时包埋亲水性、疏水性和两亲性物质。因其制备方法简单,且具有靶向性、缓释性、细胞亲和性和组织相容性,在食品领域已被成功应用于抗菌剂、酶、食品添加剂和营养素的包埋和运载。将脂质体的粒径控制在纳米尺度,可进一步提高其生物相容性、穿透性和体内靶向性。Liposomes are closed vesicles with a bilayer structure formed by phospholipids or their analogues dispersed in an aqueous phase. At present, it is generally accepted that the formation mechanism of liposomes is the interaction between phospholipids and water molecules. The polar head of phospholipids is located on the inner and outer surfaces of the lipid bilayer, and the hydrophobic tail is located in the middle of the lipid bilayer, forming a bilayer vesicle spontaneously. structure. This structural property allows liposomes to simultaneously embed hydrophilic, hydrophobic, and amphiphilic substances. Because of its simple preparation method, targeting, sustained release, cell affinity and tissue compatibility, it has been successfully applied to the embedding and delivery of antibacterial agents, enzymes, food additives and nutrients in the food field. Controlling the particle size of liposomes at the nanometer scale can further improve their biocompatibility, penetration and in vivo targeting.
目前尚无关于麝香草酚纳米脂质体的报道,传统的脂质体配方和制备方法仍存在使用有毒有机溶剂、粒径大且分散不均一、稳定性不高和工业化较难实现等不足。There is no report about thymol nanoliposomes at present, and traditional liposome formulas and preparation methods still have the disadvantages of using toxic organic solvents, large particle size and uneven dispersion, low stability and difficult industrialization.
为扩大麝香草酚的应用范围,提高其水分散性、稳定性和生理利用程度,本发明采用薄膜分散法制备麝香草酚纳米脂质体,开发一种同时具有抗氧化和抗菌作用的水分散性食品添加剂。In order to expand the scope of application of thymol and improve its water dispersibility, stability and physiological utilization, the present invention adopts thin film dispersion method to prepare thymol nano-liposomes, and develops a water-dispersed liposome with antioxidant and antibacterial effects simultaneously. Sexual food additives.
发明内容Contents of the invention
本发明的目的是提供一种麝香草酚纳米脂质体及其制备方法,作为一种新型食品、化妆品添加剂,以提高麝香草酚的分散性、稳定性和生物利用率。The object of the present invention is to provide a kind of thymol nano liposome and preparation method thereof, as a kind of novel food, cosmetic additive, to improve the dispersibility, stability and bioavailability of thymol.
为实现上述目的,本发明提供如下技术方案:To achieve the above object, the present invention provides the following technical solutions:
一种麝香草酚纳米脂质体,所述麝香草酚纳米脂质体的配方如下:按照质量组份计:其麝香草酚9-25份、大豆卵磷脂90-200份、二硬脂酰磷脂酰乙酰胺-甲氧基聚乙二醇5000 4-10份、胆固醇3-8份、抗氧化剂0.5-1.2份和吐温80 0.15-0.4份。A thymol nanoliposome, the formula of the thymol nanoliposome is as follows: in terms of mass components: 9-25 parts of thymol, 90-200 parts of soybean lecithin, distearyl Phosphatidylacetamide-methoxypolyethylene glycol 5000 4-10 parts, cholesterol 3-8 parts, antioxidant 0.5-1.2 parts and Tween 80 0.15-0.4 parts.
优选的,所述麝香草酚为提取自百里香油、牛至油的天然产物。Preferably, the thymol is a natural product extracted from thyme oil and oregano oil.
优选的,所述胆固醇为蛋黄胆固醇。Preferably, the cholesterol is egg yolk cholesterol.
优选的,所述抗氧化剂为维生素E和表没食子儿茶素没食子酸酯。Preferably, the antioxidants are vitamin E and epigallocatechin gallate.
本发明还提供一种麝香草酚纳米脂质体的制备方法,包括如下步骤:The present invention also provides a kind of preparation method of thymol nano liposome, comprises the steps:
S1、按量称取麝香草酚、维生素E、大豆卵磷脂和二硬脂酰磷脂酰乙酰胺-甲氧基聚乙二醇5000,经磁力搅拌溶于食用酒精中;S1. Weigh thymol, vitamin E, soybean lecithin and distearoylphosphatidylacetamide-methoxypolyethylene glycol 5000, and dissolve them in edible alcohol through magnetic stirring;
S2、将S1所得溶液经减压蒸发除去溶剂,溶质形成均匀薄膜;S2, the solution obtained in S1 is evaporated under reduced pressure to remove the solvent, and the solute forms a uniform film;
S3、将溶解表没食子儿茶素没食子酸酯的磷酸盐缓冲液和吐温80加入至薄膜中,冰浴超声8-10min,即得麝香草酚纳米脂质体。S3. Adding phosphate buffer solution and Tween 80 for dissolving epigallocatechin gallate into the film, and ultrasonicating in an ice bath for 8-10 minutes to obtain thymol nanoliposomes.
优选的,在S1中,大豆卵磷脂和二硬脂酰磷脂酰乙酰胺-甲氧基聚乙二醇5000质量比为10-20:1,麝香草酚与大豆卵磷脂质量比为1:8-14,维生素E与大豆卵磷脂质量比为0.005-0.01:1,磁力搅拌时间为0.5-2h,按照mg/mL为单位计,固液比为5:1。Preferably, in S1, the mass ratio of soybean lecithin to distearoylphosphatidylacetamide-methoxypolyethylene glycol 5000 is 10-20:1, and the mass ratio of thymol to soybean lecithin is 1:8 -14. The mass ratio of vitamin E to soybean lecithin is 0.005-0.01:1, the magnetic stirring time is 0.5-2h, and the solid-liquid ratio is 5:1 based on mg/mL.
优选的,在S2中,减压蒸发温度为40℃,真空度为0.05-0.1Mpa。Preferably, in S2, the decompression evaporation temperature is 40° C., and the vacuum degree is 0.05-0.1 Mpa.
优选的,在S3中,缓冲液为pH7.2的0.05M的磷酸盐缓冲液,按照以mg/ml为单位计的液固比,缓冲液体积为大豆卵磷脂用量的10-15倍,表没食子儿茶素没食子酸酯与磷酸盐缓冲液的固液比为0.0001-0.0002:1,吐温80与缓冲液的体积比为0.002-0.005:1。Preferably, in S3, the buffer is a 0.05M phosphate buffer with pH 7.2, and according to the liquid-solid ratio in mg/ml, the volume of the buffer is 10-15 times the amount of soybean lecithin, as shown in the table The solid-liquid ratio of gallocatechin gallate to phosphate buffer solution is 0.0001-0.0002:1, and the volume ratio of Tween 80 to buffer solution is 0.002-0.005:1.
优选的,在S3中,所述冰浴超声功率200w,超声2s,停止2s。Preferably, in S3, the ice bath has an ultrasonic power of 200w, ultrasonic for 2s, and stops for 2s.
本发明的技术效果和优点:本发明提供的一种麝香草酚纳米脂质体,与传统技术相比,本发明具有以下特点:Technical effect of the present invention and advantage: a kind of thymol nanoliposome provided by the invention, compared with traditional technology, the present invention has the following characteristics:
(1)所用原料多为食品级或天然来源,避免引入有毒试剂,安全性更高;(1) Most of the raw materials used are food-grade or natural sources, avoiding the introduction of toxic reagents, and have higher safety;
(2)配方中维生素E和表没食子儿茶素没食子酸酯协同发挥抗氧化作用,防止磷脂氧化,可增加脂质体的稳定性;(2) Vitamin E and epigallocatechin gallate in the formula synergistically play an anti-oxidative effect, prevent phospholipid oxidation, and increase the stability of liposomes;
(3)制得的麝香草酚纳米脂质体粒径为96-105nm,多分散指数为0.196-0.201,包封率为86.1-89.3%,常温下贮藏12d仍能保持较好的稳定性;(3) The particle size of the prepared thymol nanoliposomes is 96-105nm, the polydispersity index is 0.196-0.201, the encapsulation efficiency is 86.1-89.3%, and the storage at room temperature for 12 days can still maintain good stability;
(4)该方法操作简单,较易实现规模化工业生产。(4) The method is simple to operate, and it is easier to realize large-scale industrial production.
附图说明Description of drawings
图1 为麝香草酚纳米脂质体透射电镜照片(×20000)。Figure 1 is a transmission electron micrograph of thymol nanoliposome (×20000).
图2为麝香草酚纳米脂质体粒径和包封率随时间变化图。Fig. 2 is a time-varying graph of particle size and encapsulation efficiency of thymol nanoliposomes.
具体实施方式detailed description
下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。此处所描述的具体实施例仅仅用以解释本发明,并不用于限定本发明。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。The following will clearly and completely describe the technical solutions in the embodiments of the present invention with reference to the accompanying drawings in the embodiments of the present invention. Obviously, the described embodiments are only some, not all, embodiments of the present invention. The specific embodiments described here are only used to explain the present invention, not to limit the present invention. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without making creative efforts belong to the protection scope of the present invention.
实施例1Example 1
一种麝香草酚纳米脂质体,所述麝香草酚纳米脂质体的配方如下:按照质量组份计:其麝香草酚10mg、大豆卵磷脂100mg、二硬脂酰磷脂酰乙酰胺-甲氧基聚乙二醇5000 5mg、胆固醇3mg、维生素E 0.5mg、表没食子儿茶素没食子酸酯0.2mg、吐温80 0.16ml。A thymol nanoliposome, the formula of the thymol nanoliposome is as follows: according to mass components: its thymol 10mg, soybean lecithin 100mg, distearoylphosphatidyl acetamide-formazine Oxypolyethylene glycol 5000 5mg, cholesterol 3mg, vitamin E 0.5mg, epigallocatechin gallate 0.2mg, Tween 80 0.16ml.
称取10mg麝香草酚、100mg大豆卵磷脂、5mg二硬脂酰磷脂酰乙酰胺-甲氧基聚乙二醇5000和0.5mg维生素E,经1h磁力搅拌溶于23ml食用酒精中;在真空度为0.1Mpa,温度为40 ℃条件下减压蒸发除去溶剂,溶质形成均匀薄膜;将溶解有0.2mg表没食子儿茶素没食子酸酯的80ml磷酸盐缓冲液和0.16ml吐温80加入至薄膜中,冰浴超声10min (200W,2s开,2s停),即得麝香草酚纳米脂质体。Weigh 10mg thymol, 100mg soybean lecithin, 5mg distearoylphosphatidylacetamide-methoxy polyethylene glycol 5000 and 0.5mg vitamin E, and dissolve them in 23ml edible alcohol after 1h magnetic stirring; 0.1Mpa, the temperature is 40 ℃, and the solvent is evaporated under reduced pressure, and the solute forms a uniform film; 80ml of phosphate buffer solution with 0.2mg of epigallocatechin gallate and 0.16ml of Tween 80 are added to the film , ultrasonication in an ice bath for 10min (200W, 2s on, 2s off), to obtain thymol nanoliposomes.
所制得的麝香草酚纳米脂质体的平均粒径为96.39nm,PDI为0.201,平均包封率为88.2%,具体形状为近球形结构。The prepared thymol nanoliposomes had an average particle diameter of 96.39nm, a PDI of 0.201, an average encapsulation efficiency of 88.2%, and a specific shape of a nearly spherical structure.
实施例2Example 2
一种麝香草酚纳米脂质体,所述麝香草酚纳米脂质体的配方如下:按照质量组份计:其麝香草酚10mg、大豆卵磷脂80mg、二硬脂酰磷脂酰乙酰胺-甲氧基聚乙二醇5000 4mg、胆固醇4mg、维生素E 0.4mg、表没食子儿茶素没食子酸酯0.25mg、吐温80 0.2ml。A thymol nanoliposome, the formula of the thymol nanoliposome is as follows: according to mass components: its thymol 10mg, soybean lecithin 80mg, distearoylphosphatidylacetamide-formazine Oxy-polyethylene glycol 5000 4mg, cholesterol 4mg, vitamin E 0.4mg, epigallocatechin gallate 0.25mg, Tween 80 0.2ml.
称取10mg麝香草酚、80mg大豆卵磷脂、4mg二硬脂酰磷脂酰乙酰胺-甲氧基聚乙二醇5000和0.4mg维生素E,经1.5h磁力搅拌溶于18.8ml食用酒精中;在真空度为0.08Mpa,温度为 40 ℃条件下减压蒸发除去溶剂,溶质形成均匀薄膜;将溶解有0.25mg表没食子儿茶素没食子酸酯的100ml磷酸盐缓冲液和0.2ml吐温80加入至薄膜中,冰浴超声8min (200W,2s开,2s停),即得麝香草酚纳米脂质体。Take by weighing 10mg thymol, 80mg soybean lecithin, 4mg distearoylphosphatidylacetamide-methoxy polyethylene glycol 5000 and 0.4mg vitamin E, dissolve in 18.8ml edible alcohol through 1.5h magnetic stirring; The vacuum degree is 0.08Mpa, and the solvent is evaporated under reduced pressure at a temperature of 40°C, and the solute forms a uniform film; 100ml phosphate buffer solution and 0.2ml Tween 80 dissolved in 0.25mg epigallocatechin gallate are added to Thymol nanoliposomes were obtained in the thin film by ultrasonication in an ice bath for 8 minutes (200W, 2s on, 2s off).
所制得的麝香草酚纳米脂质体的平均粒径为98.12nm,PDI为0.196,平均包封率为89.3%,具体形状为近球形结构。The prepared thymol nanoliposomes had an average particle diameter of 98.12nm, a PDI of 0.196, an average encapsulation efficiency of 89.3%, and a specific shape of a nearly spherical structure.
实施例3Example 3
一种麝香草酚纳米脂质体,所述麝香草酚纳米脂质体的配方如下:按照质量组份计:其麝香草酚20mg、大豆卵磷脂180mg、二硬脂酰磷脂酰乙酰胺-甲氧基聚乙二醇5000 9mg、胆固醇3mg、维生素E 0.9mg、表没食子儿茶素没食子酸酯0.25mg、吐温80 0.16ml。A thymol nanoliposome, the formula of the thymol nanoliposome is as follows: according to mass components: its thymol 20mg, soybean lecithin 180mg, distearoylphosphatidyl acetamide-formazine Oxy-polyethylene glycol 5000 9mg, cholesterol 3mg, vitamin E 0.9mg, epigallocatechin gallate 0.25mg, Tween 80 0.16ml.
称取20mg麝香草酚、180mg大豆卵磷脂、9mg二硬脂酰磷脂酰乙酰胺-甲氧基聚乙二醇5000和0.9mg维生素E,经2h磁力搅拌溶于41.8ml食用酒精中;在真空度为1Mpa,温度为40 ℃条件下减压蒸发除去溶剂,溶质形成均匀薄膜;将溶解有0.25mg表没食子儿茶素没食子酸酯的180ml磷酸盐缓冲液和0.36ml吐温80加入至薄膜中,冰浴超声10min (200W,2s开,2s停),即得麝香草酚纳米脂质体。Weigh 20mg thymol, 180mg soybean lecithin, 9mg distearoylphosphatidylacetamide-methoxypolyethylene glycol 5000 and 0.9mg vitamin E, and dissolve them in 41.8ml edible alcohol after 2h magnetic stirring; The solvent is evaporated under reduced pressure at a temperature of 1Mpa and a temperature of 40°C, and the solute forms a uniform film; 180ml of phosphate buffer solution dissolved with 0.25mg of epigallocatechin gallate and 0.36ml of Tween 80 are added to the film , ultrasonication in an ice bath for 10min (200W, 2s on, 2s off), to obtain thymol nanoliposomes.
所制得的麝香草酚纳米脂质体的平均粒径为102.88nm,PDI为0.208,平均包封率为86.1%,具体形状为近球形结构。The prepared thymol nanoliposomes had an average particle diameter of 102.88nm, a PDI of 0.208, an average encapsulation efficiency of 86.1%, and a specific shape of a nearly spherical structure.
实施例 4 麝香草酚纳米脂质体的粒径及多分散指数的测定Example 4 Determination of particle size and polydispersity index of thymol nanoliposomes
采用PBS缓冲液将脂质体适当稀释后,加至专用比色皿中,采用纳米粒度仪测定其平均粒径及多分散指数。The liposomes were appropriately diluted with PBS buffer solution, added to a special cuvette, and the average particle size and polydispersity index were measured by a nanometer particle size analyzer.
实施例 5 麝香草酚纳米脂质体包封率的测定Example 5 Determination of Thymol Nanoliposome Encapsulation Efficiency
麝香草酚纳米脂质体混悬液倒入125 mL梨形分液漏斗,加入20 mL石油醚(30~60℃),振摇,使其与麝香草酚纳米脂质体充分混匀,静置分层,用旋转蒸发的方式去除石油醚,圆底烧瓶中残渣用乙酸乙酯溶解并定容至25 mL,再取1mL于10 mL容量瓶中,用乙酸乙酯定容至刻度;Pour the thymol nanoliposome suspension into a 125 mL pear-shaped separating funnel, add 20 mL of petroleum ether (30-60°C), shake to make it fully mix with the thymol nanoliposome, and statically Separate the layers, remove petroleum ether by rotary evaporation, dissolve the residue in the round-bottomed flask with ethyl acetate and dilute to 25 mL, then take 1 mL into a 10 mL volumetric flask, and dilute to the mark with ethyl acetate;
以空白脂质体同法制得的乙酸乙酯溶液为空白对照液,测定吸光值A ,根据标准曲线方程,计算未包埋麝香草酚的含量;The ethyl acetate solution prepared by the same method with blank liposomes was used as a blank control solution, and the absorbance value A was measured, and the content of unembedded thymol was calculated according to the standard curve equation;
计算公式为:包封率=[(总麝香草酚量-未包埋麝香草酚量)/总麝香草酚量]×100%The calculation formula is: encapsulation efficiency=[(total thymol amount - unembedded thymol amount)/total thymol amount]×100%
实施例 6 麝香草酚纳米脂质体的形态观察Example 6 Morphological observation of thymol nanoliposomes
将麝香草酚纳米脂质体经PBS缓冲液稀释至适当倍数后,取适量滴于铜网正面,采用滤纸吸干多余样品,再加2%磷钨酸溶液负染4min,再用滤纸吸干多余染液,室温下干燥后采用透射电子显微镜(TEM)观察。After diluting thymol nanoliposomes with PBS buffer to an appropriate multiple, take an appropriate amount and drop it on the front of the copper grid, use filter paper to blot excess samples, add 2% phosphotungstic acid solution for negative staining for 4 minutes, and then use filter paper to blot dry The excess dye solution was dried at room temperature and observed with a transmission electron microscope (TEM).
测定结果如图1-2所示。The measurement results are shown in Figure 1-2.
最后应说明的是:以上所述仅为本发明的优选实施例而已,并不用于限制本发明,尽管参照前述实施例对本发明进行了详细的说明,对于本领域的技术人员来说,其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换,凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。Finally, it should be noted that: the above is only a preferred embodiment of the present invention, and is not intended to limit the present invention. Although the present invention has been described in detail with reference to the foregoing embodiments, for those skilled in the art, it still The technical solutions recorded in the foregoing embodiments may be modified, or some of the technical features may be replaced equivalently, and any modifications, equivalent replacements, improvements, etc. made within the spirit and principles of the present invention shall be included in the within the protection scope of the present invention.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610697219.0A CN106307543B (en) | 2016-08-22 | 2016-08-22 | Thymol nano liposome and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610697219.0A CN106307543B (en) | 2016-08-22 | 2016-08-22 | Thymol nano liposome and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106307543A true CN106307543A (en) | 2017-01-11 |
CN106307543B CN106307543B (en) | 2020-02-07 |
Family
ID=57741399
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610697219.0A Active CN106307543B (en) | 2016-08-22 | 2016-08-22 | Thymol nano liposome and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106307543B (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1352551A (en) * | 1999-05-27 | 2002-06-05 | 尤罗塞尔蒂克股份有限公司 | Preparations for the application of anti-inflammatory agents |
CN1861060A (en) * | 2006-03-29 | 2006-11-15 | 李光武 | Permeability nose absorption type medicine for treating and preventing senile dementia, improving learning memory faculty and regulating blood brain barrier |
CN101366699A (en) * | 2007-08-17 | 2009-02-18 | 香港浸会大学 | Novel liposomal aerosol for the controlled release of pharmaceutically active ingredients |
CN103446055A (en) * | 2013-08-22 | 2013-12-18 | 合肥工业大学 | Preparation method of trihydroxyisoflavone lipid nanobody |
US8679550B2 (en) * | 2000-12-05 | 2014-03-25 | Tahitian Noni International, Inc. | Morinda citrifolia juice formulations comprising iridoids |
CN103857440A (en) * | 2011-06-22 | 2014-06-11 | 维奥姆生物科学有限公司 | Conjugate-based antifungal and antibacterial prodrugs |
-
2016
- 2016-08-22 CN CN201610697219.0A patent/CN106307543B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1352551A (en) * | 1999-05-27 | 2002-06-05 | 尤罗塞尔蒂克股份有限公司 | Preparations for the application of anti-inflammatory agents |
US8679550B2 (en) * | 2000-12-05 | 2014-03-25 | Tahitian Noni International, Inc. | Morinda citrifolia juice formulations comprising iridoids |
CN1861060A (en) * | 2006-03-29 | 2006-11-15 | 李光武 | Permeability nose absorption type medicine for treating and preventing senile dementia, improving learning memory faculty and regulating blood brain barrier |
CN101366699A (en) * | 2007-08-17 | 2009-02-18 | 香港浸会大学 | Novel liposomal aerosol for the controlled release of pharmaceutically active ingredients |
CN103857440A (en) * | 2011-06-22 | 2014-06-11 | 维奥姆生物科学有限公司 | Conjugate-based antifungal and antibacterial prodrugs |
CN103446055A (en) * | 2013-08-22 | 2013-12-18 | 合肥工业大学 | Preparation method of trihydroxyisoflavone lipid nanobody |
Non-Patent Citations (1)
Title |
---|
涂宗财,等: ""鱼油纳米脂质体的制备及其性质测定"", 《食品与发酵工业》 * |
Also Published As
Publication number | Publication date |
---|---|
CN106307543B (en) | 2020-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Savaghebi et al. | Manufacturing of nanoliposomal extract from Sargassum boveanum algae and investigating its release behavior and antioxidant activity | |
Tan et al. | Biopolymer-coated liposomes by electrostatic adsorption of chitosan (chitosomes) as novel delivery systems for carotenoids | |
CN103610642B (en) | A kind of liposome and preparation method who seals Epigallo-catechin gallate (EGCG) | |
CN103653179B (en) | Cinnamon essential oil nano lipidosome and preparation method thereof | |
Alexander et al. | Incorporation of phytosterols in soy phospholipids nanoliposomes: Encapsulation efficiency and stability | |
Demirci et al. | Encapsulation by nanoliposomes | |
KR100823345B1 (en) | Silica Carrying Nano-Sized Liposomal Emulsion Containing Coenzyme Kyuten and Method for Preparing the Same | |
CN104546538B (en) | A kind of VC-VE liposomes of Chitosan-coated and its preparation method and application | |
CN103637989A (en) | Preparation method of tea polyphenol nano-liposomes by ethanol injection-dynamic high-pressure microfluidization-enzymolysis | |
CN109566954A (en) | A kind of liposome/chitosan anti-bacteria, anti-oxidant coating liquid and preparation method and application embedding laurin oil and nano silver | |
CN102389150B (en) | Method for preparing liposome enveloped by catechin | |
CN106173800A (en) | A kind of food stage Folium Bambosae extract nanometer liposome and its preparation method and application | |
CN109497561B (en) | Vitamin B12Preparation method of nano liposome | |
KR20120038662A (en) | Lipid coated hydrogel and the process for preparing thereof | |
CN108741080B (en) | A kind of microalgae DHA-anthocyanin biphasic nanoliposome and preparation method thereof | |
CN109691672A (en) | A kind of liposome and preparation method thereof for encapsulating free astaxanthin | |
KR20220109059A (en) | Nanoliposome combined with metal amino clay, manufacturing method thereof, and cosmetic using same | |
CN105456193A (en) | EGCC liposome preparation and preparation method thereof | |
Zhang et al. | Preparation, characterization and stability of nanoliposomes loaded with peptides from defatted walnut (Juglans regia L.) meal | |
Liu et al. | Micron and nano hybrid ufasomes from conjugated linoleic acid, their vesiculation and encapsulation of ginsenoside Rg3 | |
CN103815545B (en) | The preparation method of squalene and tea polyphenol composition multivesicular liposome and fall base harm reduction and apply | |
CN108309936B (en) | Lycopene-loaded self-assembled nano micelle and preparation method thereof | |
CN114246336A (en) | High-rigidity cationic nano liposome and preparation method thereof | |
CN106307543B (en) | Thymol nano liposome and preparation method thereof | |
WO2020150834A1 (en) | Lecithin vesicles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |